Human CD95L-muCD8 Fusion Protein Human FAS ligand (CD95L) is a 40kd type II membrane protein that
induces apoptosis in cells expressing FAS (CD95) (1, 2). Activated human T cells release bioactive FAS ligand microvesicles (3). FAS ligand is one of the major effectors of CD8+CTL and NK activity. Loss
of FAS ligand leads to lymphoproliferative and autoimmune disease. Molecular Structure:
A soluble molecule consisting of the extracellular domain (177aa) of human CD95L fused to the extracellular domain (167aa) of murine CD8 alpha (2), with a predicted monomeric molecular weight of 38.9 kd.
Transfectant Cell Line: CHO Immunochemistry Applications:
Flow cytometry Blocking Elisa Frozen Sections Functional Application:
1 ug/ml of CD178-muCD8 will induce apoptosis in 1 x 105 human Jurkat cells in 100 ul culture volume in an overnight assay. Human CD178-muCD8 binding to CD95 positive cells is
detectable in Flow cytometry when co stained with References: 1.
T. Takahashi, et al, (1994) Intl Immunol 6: 1567-1574. 2. T. Suda, et al, (1997) J Exp Med 186: 2045-2050. 3.
M.J. Martinez-Lorenzo, et al, (1999) J Immunol 163: 1274-1281. 4. H Wajant, (2003) Essays Biochem 39:53-71. Catalog Number: 511-030-Biotinylated - 25ug |